Along the same line, it is equally important to understand the role of HH/GLI in tumor immunity in both the tumor itself as well as in the immune microenvironment of the cancer to guide and select the most efficient drug combination with more durable responses and increased response rates. The gene discussed is GLI1; the disease is neoplasm.